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Metoprolol, a moderately cardio-selective beta adrenoceptor antagonist has been shown to reduce heart rate and systolic blood pressure (Wyberg et al 1977) , and prevent part of pressor response to psychological sttess (Taylor 1981) . In potency it is similar to propranolol, but its relative beta -1 selectivity is the basis tor its potential therapeutic advantage over less selective agents (Weiner 1980) . Though propranolol has been used tor the treatment of anxiety symptoms as well as hypertension, the risk of developing depression is high (Bulpitt andBollery 1973 , Simpson and Waal-Manning 1971 , Lishman 1978 Most other anti-hypertensives also produce moderate to severe degree of depression (Lishman 1978) . McClelland (1973) reported that beta blockers, other than propranolol do not seem to induce depressive symptoms. In another study, none ot the 15 patients treated with metoprolol for their anxiety symptoms developed depression (Chaturvedi 1985) . Hence the role of metoprolol in managing concurrent depressive symptoms with hypertension needs to be examined. I would like to describe the efficacy of metoprolol in 5 cases who had neurotic depression and hypertension.
Method
The age, sex, salient clinical features, duration ot illness, duration of follow-up and improvement are presented in the table. The patients were not selected randomly, rather metoprolol was prescribed in doses ot 100-150 mg per day to these cases who had neurotic depression and hypertension. 2 of these cases had exacerbation of depressive symptoms with propranolol earlier and in other two cases anti-hypertensive (adelphane) had to be stopped because of secondary depression. Clinical assessment was done during follow-up and blood pressure was checked regularly. None of the cases had any historyoi asthma in the past or present. Blood pressure was controlled in all 5 cases. No other anti-hypertensives were prescribed. Depressive and anxiety symptoms were markedly reduced in 3 cases and moderately reduced in 2 cases. None reported any depressive symptoms. No other side effects were noticed.
Discussion
This report draws attention towards using beta selective adrenoceptor antagonists in managing patients suffering from depression and hypertension. Though there is a wide range ot drugs available for managing hypertension most produce adverse psychological reactions as depression. (Simpson and WaalManning 1971, Lishman, 1978) . Bulpitt and Dollery (1973) made extensive study of side effects of hypotensive agents and found moderate depression in more than 30 % of patients. More than 50 % of patients on propranolol had sleepiness, weakness of limbs and increased frequency of defaecation (Bulpitt and Dollery 1973) . In light of these the present report encourages use of beta selective adrenoceptor blockers since these produce fewer side effects due to minimal central action (McClelland 1973 , Chaturvedi 1985 . Because of its beneficial effects on somatic symptoms of anxiety (Chaturvedi 1985) , metoprolol can be safely used in patients with anxiety disorder and hypertension. Metoprolol has already been proved to be relatively safe in patients with bronchospastic illness (Kochweser 1979, Gilman and Goodman 1980) . Systematic trials with adequate research designs need to be conducted to assess efficacy of metoprolol in anxiety and depressive disorders.
